PhaseBio

$4.39
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.23 (-5.58%) Today
+$0.50 (+12.83%) As of 1:27 PM UTC after-hours

Why Robinhood?

You can buy or sell PhaseBio and other stocks, options, and ETFs commission-free!

About PHAS

PhaseBio Pharmaceuticals, Inc. Common Stock, also called PhaseBio, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapies for cardiopulmonary diseases. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA. The listed name for PHAS is PhaseBio Pharmaceuticals, Inc. Common Stock.

CEO
Jonathan P. Mow
Employees
40
Headquarters
Malvern, Pennsylvania
Founded
2002
Market Cap
111.46M
Price-Earnings Ratio
Dividend Yield
Average Volume
540.74K
High Today
$4.23
Low Today
$3.90
Open Price
$4.23
Volume
171.63K
52 Week High
$6.85
52 Week Low
$2.60

PHAS Earnings

-$0.98
-$0.65
-$0.33
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 29, After Hours

You May Also Like

SIJ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure